SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-185285
Filing Date
2020-07-01
Accepted
2020-07-01 17:04:24
Documents
3
Group Members
FLAGSHIP PIONEERING, INC.FLAGSHIP V VENTURELABS RX FUND, L.P.FLAGSHIP VENTURELABS IV LLCFLAGSHIP VENTURELABS V LLCFLAGSHIP VENTURELABS V MANAGER LLCFLAGSHIP VENTURES FUND IV GENERAL PARTNER LLCFLAGSHIP VENTURES FUND IV, L.P.FLAGSHIP VENTURES FUND IV-RX, L

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d936763dsc13da.htm SC 13D/A 302303
2 EX-99.1 d936763dex991.htm EX-99.1 51756
3 EX-99.2 d936763dex992.htm EX-99.2 41416
  Complete submission text file 0001193125-20-185285.txt   397846
Mailing Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MEMORIAL DRIVE, 7TH FLOOR CAMBRIDGE MA 02142 617-868-1888
Flagship Ventures Fund V, L.P. (Filed by) CIK: 0001627639 (see all company filings)

IRS No.: 611749444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Subject) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90477 | Film No.: 201005974
SIC: 2834 Pharmaceutical Preparations